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• 2006: Only 55% of Neonatal Intensive Care 
Units indicated having a written plan for 
NAS treatment.  
• 2016: The American Academy of Pediatrics 
recommends: “…each nursery should 
develop and adhere to a standardized policy 
for the evaluation and comprehensive 
treatment of infants at risk for or showing 
signs of withdrawal” 
• 2017:  Texas Health Dallas - no 
comprehensive treatment guideline for the 
care of infants with NAS.  
Background & Significance PICOT Systematic Search and Synthesis
Plan Based on Evidence Synthesis
• In neonates with Neonatal Abstinence 
Syndrome (P), how does adding non-
pharmacologic therapies to the current 
medication protocol (I) compared to 
current medication protocol alone (C) 
affect the length of stay (O) and duration 
of treatment (O)within one quarter (T)?
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NAS Education Modules: Pre/Post Test
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